Novo

Business

Novo Nordisk CEO: ‘Surprised’ about weight-loss drug traction in Europe

The popularity of Novo Nordisk’s weight-loss drugs has been unprecedented and has shown no signs of fading. It’s clearly more…

Read More »
Business

Novo Nordisk stock hits all-time high as Wegovy boosts 2023 results (NYSE:NVO)

JHVEPhoto/iStock Editorial via Getty Images Novo Nordisk (NVO) shares on Wednesday reached an all-time high as it reported a strong…

Read More »
Business

Novo Nordisk details heart benefits of weight loss drug

hapabapa/iStock Editorial via Getty Images Novo Nordisk (NVO) announced Saturday that its FDA-approved weight loss therapy Wegovy, also known as…

Read More »
Back to top button